Newsletter Subject

Apple vs Netflix Stock: Which Is Best?

From

financhill.com

Email Address

care@financhill.com

Sent On

Wed, Jul 29, 2020 04:10 PM

Email Preheader Text

Apple vs Netflix Stock: The number of technology startups is seemingly endless. Nearly every week, e

Apple vs Netflix Stock: The number of technology startups is seemingly endless. Nearly every week, entrepreneurs introduce new, more efficient methods of Market News Smart Trading. Simplified. [Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER?](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTc2OSZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEE1T0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXpNamc9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Have you seen this new extra-income hack yet? Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new strategy. Some of them are retiring from their jobs because of it. Others have paid off all their debt and bought their dream homes. [You can see their stories for yourself right here.](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTc2OSZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEE1T0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXpNamc9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored Apple vs Netflix Stock: Which Is Best? Apple vs Netflix Stock: The number of technology startups is seemingly endless. Nearly every week, entrepreneurs introduce new, more efficient methods of managing the tasks of daily life. All are hoping to follow in the footsteps of technology pioneers like Apple, Facebook, Netflix, Amazon, and Google. They want to transform the world – and make […] [Continue Reading >](~/AACAmgA~/RgRhBCNbP0Q8aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9hcHBsZS12cy1uZXRmbGl4LXN0b2NrVwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) [Up to 93.2% accuracy trading before the open?](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTc5NCZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVFV6TkNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSTBNREk9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) We're just getting word of this... an all new way to trade - before the bell rings on Wall Street - allowing traders to achieve up to 1,139% return! Two hedge fund managers teamed up to develop the all-new strategy allowing YOU to trade outside of the competition... [Click here to login to the "7AM Super Surges" broadcast](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTc5NCZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVFV6TkNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSTBNREk9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored Is Quanterix The Future Of Healthcare Is Quanterix Stock A Buy? Quanterix seeks to uncover the biology behind infectious diseases and provide better management of health overall. Tying these opposite spectrum ends together is the endgoal– but is it a tight knot or one that could quickly unravel when it comes to Quanterix stock? And at the heart of the matter – […] [Continue Reading >](~/AACAmgA~/RgRhBCNbP0Q-aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy1xdWFudGVyaXgtc3RvY2stYS1idXlXA3NwY0IKACVhnyFfVa0N1FIbdHJpc3RyYW1iYWxkd2luODhAZ21haWwuY29tWAQAAAAB) [Small Biotech Firm Stuns World](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTYyNCZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEV4TkNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXlNVEk9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) On November 16, 2016 a small biotech used a radical new treatment to restore blindness in mice. CBS News called this breakthrough "the most consequential discovery in biomedicine this century." [Investors who get in early are set to earn 46,751% returns.](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTYyNCZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEV4TkNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXlNVEk9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored Will I Be Rich One Day? Will I Be Rich One Day? Everyone wants to have enough money to enjoy a comfortable lifestyle. There’s a difference between having enough money to enjoy life and being rich, though. Becoming rich requires a lot of discipline and knowledge. No one can guarantee that you will be rich one day. But you can use […] [Continue Reading >](~/AACAmgA~/RgRhBCNbP0Q8aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy93aWxsLWktYmUtcmljaC1vbmUtZGF5VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) [Brilliant German Technical Analyst Makes U.S. Debut](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTgxNiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVFl5TWlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSTBOREE9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Hey this is Rob Booker, and I wanted to tell you about my friend Dr. Gregor Bauer. This guy is a brilliant German technical analyst who advises his government, but he's never taught in the U.S. before... until now. The opportunities created by this crisis are too much for even a stoic German to pass up. You have to hear what he has to say. [Catch his groundbreaking documentary here](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTgxNiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVFl5TWlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSTBOREE9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored Cinedigm Stock Forecast Cinedigm Stock Forecast: Cinedigm [CIDM] has been in the news. The company has been going through a lot of changes and winning headlines in the process. On June 8, 2020, Cinedigm issued a press release announcing the launch of a new network called CONtv Anime. The new offering will be available across the company’s 120-million device […] [Continue Reading >](~/AACAmgA~/RgRhBCNbP0Q9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9jaW5lZGlnbS1zdG9jay1mb3JlY2FzdFcDc3BjQgoAJWGfIV9VrQ3UUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAE~) [Our #1 Takeover Target for June](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTU0MyZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc1T0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNemM9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Can you imagine doubling your money before noon? On May 4th, 2020, investors made 154% in one morning with the Stemline Therapeutics takeover...on March 4, 2020, they made 147% in one morning with the Forty-Seven takeover...and on December 9, 2019, they made 100% in one morning with the Arqule was takeover. [Get our next takeover target here ](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTU0MyZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc1T0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNemM9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored 3 Stocks That Could Be The Next Berkshire Hathaway Stocks That Could Be The Next Berkshire Hathaway: There isn’t an investor anywhere who wouldn’t want a slice of Berkshire Hathaway. But if you’re new to investing, you might not A) know about this conglomerate or B) have the finances to invest Class A style. Buying shares in companies poised to be the next Berkshire […] [Continue Reading >](~/AACAmgA~/RgRhBCNbP0RWaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9zdG9ja3MtdGhhdC1jb3VsZC1iZS10aGUtbmV4dC1iZXJrc2hpcmUtaGF0aGF3YXlXA3NwY0IKACVhnyFfVa0N1FIbdHJpc3RyYW1iYWxkd2luODhAZ21haWwuY29tWAQAAAAB) [You Could Make $300 to $1100 Per Contract With This Simple Trade](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTU5MiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEExTXlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhPRGM9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Imagine getting really good at mastering just ONE simple trade. A trade that appears like clockwork between 9:30-10:45am on most trading days. This free step-by-step guide, by options expert, Dave Acquino, shows you how to spot and take these trades so you can walk away with daily profits! [CLICK HERE for instant access.](~/AACAmgA~/RgRhBCNbP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTU5MiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlOVEExTXlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhPRGM9VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored View this email [online](~/AACAmgA~/RgRhBCNbP0QaaHR0cDovL2ZpbmFuY2hpbGwuY29tL2Jsb2dXA3NwY0IKACVhnyFfVa0N1FIbdHJpc3RyYW1iYWxkd2luODhAZ21haWwuY29tWAQAAAAB) if it doesn't display correctly. This newsletter is not financial advice. Please read our [Disclaimer](~/AACAmgA~/RgRhBCNbP0QbaHR0cDovL2ZpbmFuY2hpbGwuY29tL3Rlcm1zVwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~). To unsubscribe from Financhill, [click here](~/AACAmgA~/RgRhBCNbP0RXaHR0cDovL2ZpbmFuY2hpbGwuY29tL0dyZWF0T2ZmZXJzRm9yWW91LzBjNmVhZDhkMjNlMzEwMGRmOGQ5ZWE1NWFiY2YyOTk3LTE5NzY1MTA2LTg2OTE1VwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~). Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email. The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: [Characteristics and Risks of Standardized Options](~/AACAmgA~/RgRhBCNbP0RFaHR0cDovL3d3dy5vcHRpb25zY2xlYXJpbmcuY29tL2Fib3V0L3B1YmxpY2F0aW9ucy9jaGFyYWN0ZXItcmlza3MuanNwVwNzcGNCCgAlYZ8hX1WtDdRSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAQ~~). The Financhill.com educational training program and software services are provided to improve financial understanding. The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.

Marketing emails from financhill.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

03/11/2024

Sent On

29/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.